Study of Subcutaneous and Intravenous ALXN1720 With and Without rHuPH20 in Healthy Subjects
Clinical trial NCT04920370 · COMPLETED
Trial details
- NCT number
- NCT04920370
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-04
- Primary completion
- 2021-11-16
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.